Why there's liquid left in your Mounjaro pen after an injection

Step 1: what the pen actually delivers during a Mounjaro injection

The Mounjaro KwikPen holds enough solution for four weekly injections at the prescribed dose. When you press the injection button and hold it in place, the plunger rod advances by a precise, pre-set increment. It does not run to the bottom of the cartridge. The mechanism is calibrated to push exactly the right volume of tirzepatide solution into the subcutaneous tissue, no more, no less. Once the full ten seconds have elapsed and you withdraw the pen, the plunger stops where the dose mechanics dictate, not where the cartridge runs dry.

This means the viewing window will always show some solution after a successful injection. That is not a fault or a sign of incomplete delivery. Eli Lilly's design accounts for the fact that small amounts of fluid cling to the inside of the cartridge, the needle hub, and the dead space at the needle tip. The overfill compensates, so the delivered dose remains accurate. The Mounjaro injection guide covers the full technique in detail if you want to revisit the hold-time and withdrawal steps.

One practical note: if your pen arrived with DPD in its plain box and you are using it for the first time, the cartridge will look fuller than it will after subsequent doses, completely normal, and a reassuring sign the pen has not been tampered with in transit.

Step 2: recognising normal residue versus a potential problem

After a correctly completed injection, the amount of liquid remaining in the window should look broadly consistent from week to week at the same dose. A thin layer of solution at the base of the cartridge is standard. Where things are worth a second look is if the window still looks mostly full after what felt like a normal injection, that could point to the button not being pressed fully, the needle not seating correctly, or the pen being held at the skin for less than the full ten seconds.

The NHS patient information for tirzepatide, available via the NHS tirzepatide medicines page, recommends checking that the dose indicator shows the injection is complete before withdrawing. If you are unsure whether your pen clicked through its cycle properly, do not attempt a second injection, contact your prescriber or call our team through the support page.

A separate but related question is liquid appearing on the skin surface after withdrawal. That is a different scenario (solution that has tracked back along the needle channel rather than an incomplete dose) and there is a dedicated page on liquid on the skin after a Mounjaro injection that explains what usually causes it and what to do.

Step 3: disposing of the pen correctly after the final dose

When you have used all four injections from the pen, residual solution will still be present. Do not try to extract it. The SmPC is clear that the pen should be disposed of after the fourth dose regardless of visible remaining fluid, attempting to use that excess risks an inaccurate dose and potential needle-stick injury. Remove the needle carefully, replace the pen cap, and place the whole unit into a sealed sharps container before disposal via your local sharps collection point.

Storage between doses matters too: the pen should be kept refrigerated between 2°C and 8°C with the cap on and the needle removed. For the precise room-temperature window and any other storage details, the Mounjaro Patient Information Leaflet (available on the electronic Medicines Compendium) is the authoritative source, refer to it rather than relying on memory or online summaries.

When the residual liquid question is really about something else

Occasionally, patients asking about why there is liquid left in a Mounjaro pen are actually worried about whether the dose worked at all, particularly if nausea, which typically signals that the medicine is active, did not appear. Side-effect profiles vary considerably from person to person and between doses; the absence of nausea is not evidence of a missed dose. If you genuinely believe an injection was not delivered, the right step is to contact your prescriber on the same day, explain what happened, and follow their clinical guidance. Do not self-administer a repeat dose.

If you are exploring whether tirzepatide is right for you, or you are mid-treatment and have questions about titration, our Mounjaro overview covers the licensed schedule and eligibility. And if cost is part of what you are weighing up, our guide to Mounjaro pricing in the UK explains what private treatment actually costs and what a single transparent price should include. For anything that feels urgent or medically uncertain, including if you are wondering why there is still liquid in your Mounjaro pen after completing all the steps, reach out to our aftercare team, or, if it is a safety concern, contact your GP or call NHS 111.

When you are ready to start or continue treatment with a clinical team who review every prescription personally, check your eligibility with a free consultation.